Markus Hörer
Fondatore presso FREELINE THERAPEUTICS HOLDINGS PLC
Provenienza dei contatti di primo grado di Markus Hörer
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Subsidiary | Biotechnology | 28 | |
Freeline Therapeutics GmbH
Freeline Therapeutics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Ascend Gene & Cell Therapies Ltd., Freeline Therapeutics GmbH is a German biotechnology company that focuses on liver directed gene therapies for bleeding disorders and other chronic diseases. The company is based in Planegg, Germany. The company has a pipeline of gene therapies that have the potential to change the lives of people with chronic, debilitating diseases. Freeline has two key enabling platforms critical to realizing AAV gene therapy across its indications\: its proprietary AAV vector platform and its high-performing manufacturing platform. The company was founded in 2015, and the CEOs are Markus Hörer and Karl Christian Heller. Freeline Therapeutics was acquired by Ascend Gene & Cell Therapies Ltd. from Freeline Therapeutics Holdings Plc on February 10, 2023 for $25.83 million.
1
| Subsidiary | Miscellaneous Commercial Services | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Markus Hörer tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Freeline Therapeutics Ltd.
Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Founder Chief Executive Officer Director/Board Member Founder Director/Board Member Human Resources Officer | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Administrative Officer | |
Novalgen Ltd.
Novalgen Ltd. BiotechnologyHealth Technology Part of Convergys Capital Ltd., Novalgen Ltd. is a clinical stage immunology company based in Northwood Hills, UK. Novalgen is developing breakthrough immunotherapies for people with immunologically driven diseases using their autoregulation platform. The British company's lead program, NVG-111, is an ROR1-targeting bispecific antibody T-cell engager for the treatment of both hematological malignancies and solid tumors using their breakthrough bispecific antibody technology. The company's lead AR program, NVG-222, builds on the success of NVG-111 and is primed for entry into the clinic in 2024. The company was founded by Amit Chunilal Nathwani and has been the CEO since incorporation. | Biotechnology | Founder Director/Board Member Corporate Officer/Principal | |
SHIRE | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Georgetown University | College/University | Undergraduate Degree Undergraduate Degree | |
University College London | College/University | Corporate Officer/Principal | |
Royal Free Hospital Medical School | College/University | Corporate Officer/Principal | |
ABEONA THERAPEUTICS INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
BECTON, DICKINSON AND COMPANY | Medical Specialties | Corporate Officer/Principal | |
Marshall University | College/University | Undergraduate Degree | |
Evox Therapeutics Ltd.
Evox Therapeutics Ltd. BiotechnologyHealth Technology Evox Therapeutics Ltd. develops and markets transformational therapeutics. The firm creates novel exosome-based biotherapeutics for the treatment of various severe diseases with limited options for patients and their families. The company was founded by Matthew Wood, Per Lundin, and Samir EL Andaloussi in 2016 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Director/Board Member | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
ORCHARD THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member | |
University of Salford | College/University | Undergraduate Degree | |
New Context Ltd. | Director/Board Member | ||
GLOBAL BLOOD THERAPEUTICS, INC. | Pharmaceuticals: Major | Human Resources Officer | |
The Pennsylvania State University | College/University | Undergraduate Degree | |
Mercyhurst University | College/University | Graduate Degree | |
University of Aberdeen | College/University | Undergraduate Degree | |
The Open University | College/University | Doctorate Degree | |
Concordia University | College/University | Masters Business Admin | |
AQUESTIVE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
PURETECH HEALTH PLC | Biotechnology | Chief Tech/Sci/R&D Officer | |
Puretech Health LLC
Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Corporate Officer/Principal | |
AMICUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Sales & Marketing | |
BIOGEN INC. | Pharmaceuticals: Major | Public Communications Contact | |
WAVE LIFE SCIENCES LTD. | Biotechnology | Corporate Officer/Principal | |
York University | College/University | Undergraduate Degree | |
Bayer HealthCare
Bayer HealthCare Medical/Nursing ServicesHealth Services Part of Bayer AG, Bayer HealthCare is a company that provides medical care and animal health care services. The company is based in Tarrytown, NY. | Medical/Nursing Services | Corporate Officer/Principal | |
X4 PHARMACEUTICALS, INC. | Biotechnology | Corporate Officer/Principal | |
Wave Life Sciences USA, Inc.
Wave Life Sciences USA, Inc. Electric UtilitiesUtilities Part of Wave Life Sciences Ltd., Wave Life Sciences USA, Inc. is a company that provides nucleic acid therapeutics. The company is based in Cambridge, MA. The company was founded in 2012 by Gregory L. Verdine, Takeshi Wada. The CEO is Paul B. Bolno. | Electric Utilities | Corporate Officer/Principal | |
Georgetown University Law Center | College/University | Graduate Degree | |
New York State Bar Association
New York State Bar Association Miscellaneous Commercial ServicesCommercial Services New York State Bar Association is a non-profit organization, which provides legal services and offers a membership program for lawyers. It also publishes an array of books, bar journals, law digest, and State Bar news. The company was founded in 1876 and is headquartered in Alban, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
The District of Columbia Bar
The District of Columbia Bar Miscellaneous Commercial ServicesCommercial Services The District of Columbia Bar provides legal services. The private company is based in Washington. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Akin, Gump, Strauss, Hauer & Feld LLP
Akin, Gump, Strauss, Hauer & Feld LLP Miscellaneous Commercial ServicesCommercial Services Akin Gump Strauss Hauer & Feld LLP provides legal services. The firm's areas of practice includes appellate, litigation, business and commercial litigation, dispute resolution, government contracts, internal investigations, labor and employment, oil and gas patent, trademark and copyright infringement, product liability and toxic tort securities litigation. The company was founded in 1971 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Human Resources Officer | |
LEXICON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
AEGERION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
KALEIDO BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
University of the Witwatersrand | College/University | Doctorate Degree | |
George Mason University | College/University | Doctorate Degree | |
TAYSHA GENE THERAPIES, INC. | Biotechnology | Director/Board Member | |
Georgetown University School of Medicine | College/University | Doctorate Degree | |
Auregen Biotherapeutics, Inc.
Auregen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Auregen Biotherapeutics, Inc. provides biotechnology services. The CEO of the American company is Richard John Davies. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Auregen Biotherapeutics SA
Auregen Biotherapeutics SA Packaged SoftwareTechnology Services Auregen Biotherapeutics SA develops three dimensional (3D) bioprinting technology for patients with rare disorders. The company is headquartered in Geneva, Switzerland. | Packaged Software | Chief Tech/Sci/R&D Officer | |
EUSA Pharma, Inc.
EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products. The company currently has eight products on the market, including Caphosol for the treatment of oral mucositis, a common and debilitating side-effect of radiation therapy and high-dose chemotherapy, ProstaScint for imaging the extent and spread of prostate cancer, Quadramet for the treatment of pain in patients whose cancer has spread to the bones, Erwinase and Kidrolase for the treatment of acute lymphoblastic leukemia and the antibiotic surgical implant Collatamp. EUSA also has several products in late-stage development, notably Collatamp topical, a gentamicin impregnated collagen sponge for the prevention and treatment of infected skin ulcers, and CollaRx bupivacaine implant for local post-surgical pain control. Founded in 2006, EUSA Pharma is supported by a consortium of leading life science capital investors, comprising TVM Capital, Essex Woodlands, 3i, Goldman Sachs, Advent Venture Partners, SV Life Sciences, NeoMed and NovaQuest. Since its foundation, the company has raised over $275 million, and completed several significant transactions, including the acquisitions of Cytogen Corporation, Talisker Pharma Ltd, the French biopharmaceutical company OPi SA and the European antibiotic and pain control business of Innocoll Pharmaceuticals Inc. As part of its rapid growth strategy the company has established commercial infrastructure in the US, a pan-European presence covering over 20 countries and a wider distribution network in a further 25 territories. EUSA Pharma plans to continue its aggressive program of acquisitions and in-licensing within its specialist areas of medical and geographic focus, in line with its ambitious target to create a rapidly growing $1 billion company by the beginning of the next decade. | Pharmaceuticals: Major | Director of Finance/CFO | |
University of Copenhagen | College/University | Graduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 31 |
Regno Unito | 13 |
Canada | 3 |
Irlanda | 2 |
Singapore | 2 |
Settori
Health Technology | 25 |
Consumer Services | 17 |
Commercial Services | 5 |
Finance | 2 |
Health Services | 2 |
Posizioni
Director/Board Member | 56 |
Corporate Officer/Principal | 52 |
Independent Dir/Board Member | 23 |
Chief Tech/Sci/R&D Officer | 22 |
Undergraduate Degree | 19 |
Contatti più connessi
Insiders | |
---|---|
Julia Gregory | 22 |
Chris Hollowood | 18 |
Theresa Heggie | 16 |
Jeffrey Chodakewitz | 15 |
Julie Krop | 12 |
Colin Love | 11 |
Mark Baldry | 9 |
Michael Parini | 9 |
Eric Fink | 8 |
Brian Silver | 8 |
Natalia Misciattelli | 7 |
Martin Andrews | 7 |
Amit Chunilal Nathwani | 7 |
Pamela Foulds | 6 |
Stephen P. Diamond | 5 |
- Borsa valori
- Insiders
- Markus Hörer
- Connessioni Società